*you need to join by phone if you want to ask the doctor questions.
The use of the immune system to treat patients with AML is being heavily pursued as a strategy to more effectively fight AML and give patients with relapsed or refractory disease a better chance at achieving remission or a cure.
Immunotherapy in the form of allogeneic stem cell transplant has been a foundation of curative therapy in AML since the 1970s. While the effectiveness and tolerability of stem cell transplant has improved over the years, significant limitations still exist, warranting the development of new and improved immunotherapy options.
Join us live September 30th at 12 PM Central to learn from Dr. John Reagan, an AML expert from Rhode Island Hospital, about what steps you can take if you have relapsed or refractory AML. He will be discussing what immunotherapy is, it’s current use in AML and his open clinical trial looking at whether the FDA approved drug Gemtuzumab, followed by an infusion of blood cells called leukocytes from a donor, can stimulate the immune system to potentially fight AML.
Director of Hematology, Rhode Island Hospital
Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
(800) 930-5159
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.